ISSN:
1439-6637
Keywords:
Keywords Cost-effectiveness
;
Screening
;
Chlamydia trachomatis
;
Reinfection
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Chlamydia trachomatis in general practice. A decision-analysis model was constructed for health effects of the program: averted pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, infertility, and neonatal pneumonia (major outcomes averted). We explicitly included reinfection due to failed partner referral in the model. Cost-effectiveness estimates included direct and indirect costs. At current test costs – of US$ 17 for ligase chain reaction test on urine – only screening women aged 15–19 years is cost saving. Net costs per cured woman and major outcome averted for screening women younger than 30 are below US$ 150 and US$ 410, respectively. These results are sensitive to reinfection. We conclude that explicit inclusion of reinfection is relevant for valid estimations of cost-effectiveness of screening for C. trachomatis. Based on cost-effectiveness considerations, we suggest implementation of a screening program in Amsterdam for sexually active women younger than 30 years.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s101980070003
Permalink